(Q45404731)

14 December 2017

title

Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice (English)

1 reference

14 December 2017

0 references

1 reference

hepatitis E virus

1 reference

4

Vidya A Arankalle

1 reference

14 December 2017

2

Kavita S Lole

1 reference

14 December 2017

Tejaswini M Deshmukh

1

1 reference

14 December 2017

Anuradha S Tripathy

series ordinal

3

1 reference

14 December 2017

language of work or name

English

0 references

publication date

9 April 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

25

1 reference

14 December 2017

issue

22

1 reference

14 December 2017

page(s)

4350-4360

1 reference

Aetiology of acute sporadic non-A, non-B viral hepatitis in India

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

High Mortality Associated with an Outbreak of Hepatitis E among Displaced Persons in Darfur, Sudan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Incidence and severity of viral hepatitis in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Consumption of wild boar linked to cases of hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Cross‐challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Prevalence of anti-hepatitis E virus antibodies in different Indian animal species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

DNA vaccination against hepatitis E virus infection in cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Hepatitis E virus chimeric DNA vaccine elicits immunologic response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Challenges in creating a vaccine to prevent hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Successful passive and active immunization of cynomolgus monkeys against hepatitis E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Safety and efficacy of a recombinant hepatitis E vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity-capture RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

The regulation and maturation of antiviral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

Genetic and experimental evidence for cross-species infection by swine hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.040

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.03.040

1 reference

release_j5ukmmcogranjkfarvffhtlznu

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j5ukmmcogranjkfarvffhtlznu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference